U.S. market Closed. Opens in 11 hours 36 minutes

IOBT | IO Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue756.00K540.00KN/AN/AN/A
Gross Profit-756.00K-540.00KN/AN/AN/A
Operating Expenses90.69M71.42M41.23M10.14M9.91M
Selling, General & Admin22.86M24.44M11.08M1.68M1.98M
Research & Development67.83M46.99M30.15M8.46M7.94M
Other Operating ExpensesN/AN/A-26.54M-1.99M-781.00K
Operating Income-91.44M-71.42M-41.23M-10.14M-9.91M
Other Expenses / Income6.21M1.24M-26.58M-1.90M-830.00K
Before Tax Income-85.23M-70.19M-67.81M-12.04M-10.74M
Income Tax Expenses852.00K1.27M68.00K26.00K6.00K
Net Income-86.08M-71.46M-67.88M-12.07M-10.75M
Interest ExpensesN/A302.00K361.00K26.00K6.00K
Basic Shares Outstanding43.54M28.82M28.82M28.82M28.82M
Diluted Shares Outstanding43.54M28.82M28.82M28.82M28.82M
EBITDA-90.69M-70.01M-67.77M-12.13M-10.69M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-85.23M-69.88M-67.45M-12.02M-10.74M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙